Designed for Precision

We engineer precision antibodies that eliminate disease-causing immune cells while sparing healthy ones. By targeting only harmful populations, our therapies preserve immune balance and achieve durable remission without broad immune suppression. Our bispecific platform harnesses RA-selective target expression to precisely identify and destroy disease-driving cells at their source.